Revium Rx RVRC
OTC RVRC
$1.43 +0.00 (+0.00%)
At close: Sep 3, 2026 · 4:00 PM EDT

Revium Rx (RVRC) Assets Average (2026)

Revium Rx's (RVRC) quarterly Assets Average came in at $7.7 million in Q2 2026.

Analysis

Revium Rx (RVRC) Assets Average (2026) Analysis & Trends

Revium Rx has disclosed Assets Average across 1 years of filings, most recently posting $7.7 million for Q2 2026.

  • In Q2 2026, Assets Average changed N/A year-over-year to $7.7 million; the TTM figure through Jun 2026 stood at $7.7 million (changed N/A YoY), while the FY2025 annual figure was $14.3 million, changed N/A from the prior year.
  • Assets Average came in at $7.7 million for Q2 2026 at Revium Rx.
  • In the past five years, Assets Average ranged from a high of $7.7 million in Q2 2026 to a low of $7.7 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Assets Avg. (Qtr)
1 Amgen 236.37 Bn 222.38 Bn 7.24 Bn 94.07 Bn
2 Gilead Sciences 187.38 Bn 184.12 Bn 6.22 Bn 52.82 Bn
3 Vertex Pharmaceuticals 138.36 Bn 130.51 Bn 2.84 Bn 26.95 Bn
4 Regeneron Pharmaceuticals 85.09 Bn 77.10 Bn 3.93 Bn 41.30 Bn
5 Argenx Se 63.93 Bn 58.75 Bn 1.37 Bn -
6 Moderna 58.07 Bn 52.94 Bn 52.00 Mn 11.22 Bn
7 Alnylam Pharmaceuticals 35.59 Bn 32.28 Bn 992.69 Mn 5.34 Bn
8 Biogen 32.63 Bn 31.34 Bn 1.96 Bn 30.78 Bn
9 Insmed 27.57 Bn 26.41 Bn 358.27 Mn 2.09 Bn
10 Revium Rx 86.84 Mn 85.34 Mn - 7.71 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 7.71 Mn